• Increase font size
  • Default font size
  • Decrease font size
Latest News
Filter 
# Article Title
1 Positron Announces Strategic Alliance with Covidien; to Develop Innovative Distribution Model
2 Inadequate Response to Clopidogrel Leads to Higher Incidence of Major Adverse Cardiac Events in Patients Who have Undergone PCI
3 Phone Alerts
4 Collaboration Is The Name of The Game
5 FDA Issues Final Rules to Help Patients Gain Access to Investigational Drugs
6 Head of FDA's Device Division Resigns
7 OSI Pharma Announces More Phase 3 Results for Tarceva
8 Maxygen Announces Second Quarter 2009 Earnings Release Date
9 Nephros (OTC:NEPH) Completes $1.25 Million Private Placement
10 Inovio Biomedical Universal Influenza Vaccines Demonstrate 100% Protection Against Current Pandemic
11 Elron Receives FDA Clearance for Insulin Delivery System
12 Teva Reports Second Quarter 2009 Results
13 Phase Forward Reports Second Quarter 2009 Results
14 MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 3, 2009
15 Inhibitex to Host Conference Call to Report Second Quarter 2009 Financial Results on August 11, 2009
16 Phase Forward Acquires Maaguzi LLC, Innovative Provider of Web-Based Electronic Patient Reported Outcomes (ePRO) and Late Phase Solutions
17 Vertex Pharmaceuticals Announces the Date of its Second Quarter 2009 Financial Results Conference Call and Webcast
18 FDA Calendar, Clinical Trials, FDA Decisions
19 Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms
20 International Drug and Explosives Detection Firm IDenta Corp. CEO Reports on Future Direction of Company
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Page 1 of 65

Get Free Email and Phone News Alerts

* Your email address:
* Preferred Format:
* Enter the security code shown: